Recent clinical trials in valvular heart disease.
Curr Opin Cardiol
; 32(4): 343-347, 2017 Jul.
Article
en En
| MEDLINE
| ID: mdl-28441151
ABSTRACT
PURPOSE OF REVIEW With widespread adoption of transcatheter aortic valve replacement, there has been a change in the approach to management of valvular heart disease. New interest has taken hold in transcatheter therapies for valvular heart disease, as well as research into pathophysiology and progression of disease. Additionally, several key trials have further refined our understanding of surgical management of valvular heart disease. This review will elucidate recent clinical trial data leading to changes in practice. RECENT FINDINGS:
There have been several landmark trials expanding the indications for transcatheter aortic valve replacement. Additionally, although still early, trials are beginning to demonstrate the feasibility and safety of transcatheter mitral valves. Options for transcatheter management of right-sided valvular disease continue to evolve, and these are areas of active investigation.SUMMARY:
The emergence of novel therapies for valvular heart disease has expanded the management options available, allowing physicians to better individualize treatment of patients with valvular heart disease. This review will focus on the recent (within 2 years) trials in this field of interest.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Prótesis Valvulares Cardíacas
/
Implantación de Prótesis de Válvulas Cardíacas
/
Reemplazo de la Válvula Aórtica Transcatéter
/
Enfermedades de las Válvulas Cardíacas
Límite:
Humans
Idioma:
En
Año:
2017
Tipo del documento:
Article